Ourania Tatsis's most recent trade in Verve Therapeutics Inc was a trade of 42,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | Ourania Tatsis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 42,200 | 42,200 | - | - | Stock Option (right to buy) | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 499.99 per share. | 10 Mar 2025 | 3,242 | 51,239 (0%) | 0% | 500.0 | 1,620,968 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 485.49 per share. | 04 Mar 2025 | 4,058 | 54,481 (0%) | 0% | 485.5 | 1,970,118 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 479.61 per share. | 26 Feb 2025 | 4,962 | 59,069 (0%) | 0% | 479.6 | 2,379,825 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 475.34 per share. | 26 Feb 2025 | 530 | 58,539 (0%) | 0% | 475.3 | 251,930 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 483.28 per share. | 24 Feb 2025 | 3,310 | 64,385 (0%) | 0% | 483.3 | 1,599,657 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 480.95 per share. | 24 Feb 2025 | 354 | 64,031 (0%) | 0% | 480.9 | 170,256 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.46 per share. | 14 Feb 2025 | 2,293 | 67,939 (0%) | 0% | 463.5 | 1,062,714 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 455.06 per share. | 14 Feb 2025 | 244 | 67,695 (0%) | 0% | 455.1 | 111,035 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 6,211 | 70,232 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.98 per share. | 10 Feb 2025 | 2,143 | 64,331 (0%) | 0% | 468.0 | 1,002,881 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 459.83 per share. | 10 Feb 2025 | 310 | 64,021 (0%) | 0% | 459.8 | 142,547 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 10,262 | 59,360 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 7,114 | 66,474 (0%) | 0% | 0 | Common Stock | |
| Verve Therapeutics Inc | Ourania Tatsis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 267,541 | 267,541 | - | - | Stock Option (right to buy) | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 460.00 per share. | 03 Jun 2024 | 2,175 | 49,098 (0%) | 0% | 460 | 1,000,500 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 439.11 per share. | 30 May 2024 | 2,350 | 53,523 (0%) | 0% | 439.1 | 1,031,909 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 445.00 per share. | 30 May 2024 | 2,250 | 51,273 (0%) | 0% | 445 | 1,001,250 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 431.79 per share. | 23 Feb 2024 | 3,309 | 56,158 (0%) | 0% | 431.8 | 1,428,793 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 425.70 per share. | 23 Feb 2024 | 354 | 55,804 (0%) | 0% | 425.7 | 150,698 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 421.77 per share. | 21 Feb 2024 | 360 | 59,467 (0%) | 0% | 421.8 | 151,837 | Common Stock |
| Vertex Pharma | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 424.01 per share. | 16 Feb 2024 | 4,499 | 63,680 (0%) | 0% | 424.0 | 1,907,621 | Common Stock |
| Vertex Pharma | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 420.58 per share. | 16 Feb 2024 | 3,373 | 60,307 (0%) | 0% | 420.6 | 1,418,616 | Common Stock |
| Vertex Pharma | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 420.79 per share. | 16 Feb 2024 | 480 | 59,827 (0%) | 0% | 420.8 | 201,979 | Common Stock |
| Vertex Pharma | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 422.74 per share. | 09 Feb 2024 | 2,100 | 68,493 (0%) | 0% | 422.7 | 887,754 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 420.24 per share. | 09 Feb 2024 | 314 | 68,179 (0%) | 0% | 420.2 | 131,955 | Common Stock |
| Vertex Pharma | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 7,866 | 63,479 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 7,114 | 70,593 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 6,976 | 55,613 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 355.00 per share. | 23 Aug 2023 | 2,500 | 48,637 (0%) | 0% | 355 | 887,500 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 345.79 per share. | 10 Aug 2023 | 5,750 | 51,137 (0%) | 0% | 345.8 | 1,988,293 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.12 per share. | 24 Feb 2023 | 3,308 | 57,159 (0%) | 0% | 289.1 | 956,409 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 287.20 per share. | 24 Feb 2023 | 283 | 56,876 (0%) | 0% | 287.2 | 81,278 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 288.33 per share. | 24 Feb 2023 | 51 | 56,825 (0%) | 0% | 288.3 | 14,705 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 289.30 per share. | 24 Feb 2023 | 20 | 56,805 (0%) | 0% | 289.3 | 5,786 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.85 per share. | 17 Feb 2023 | 4,498 | 60,947 (0%) | 0% | 292.8 | 1,317,239 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 293.83 per share. | 17 Feb 2023 | 207 | 60,591 (0%) | 0% | 293.8 | 60,823 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 292.85 per share. | 17 Feb 2023 | 145 | 60,798 (0%) | 0% | 292.8 | 42,463 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 294.77 per share. | 17 Feb 2023 | 124 | 60,467 (0%) | 0% | 294.8 | 36,551 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 291.00 per share. | 17 Feb 2023 | 4 | 60,943 (0%) | 0% | 291 | 1,164 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 299.60 per share. | 14 Feb 2023 | 135 | 65,496 (0%) | 0% | 299.6 | 40,446 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 295.89 per share. | 14 Feb 2023 | 71 | 65,694 (0%) | 0% | 295.9 | 21,008 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 300.59 per share. | 14 Feb 2023 | 51 | 65,445 (0%) | 0% | 300.6 | 15,330 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 297.98 per share. | 14 Feb 2023 | 43 | 65,631 (0%) | 0% | 298.0 | 12,813 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 296.50 per share. | 14 Feb 2023 | 20 | 65,674 (0%) | 0% | 296.5 | 5,930 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 298.26 per share. | 10 Feb 2023 | 2,995 | 66,040 (0%) | 0% | 298.3 | 893,289 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.33 per share. | 10 Feb 2023 | 1,377 | 69,035 (0%) | 0% | 294.3 | 405,292 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 298.98 per share. | 10 Feb 2023 | 120 | 65,840 (0%) | 0% | 299.0 | 35,878 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 298.12 per share. | 10 Feb 2023 | 78 | 65,960 (0%) | 0% | 298.1 | 23,253 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 299.88 per share. | 10 Feb 2023 | 64 | 65,776 (0%) | 0% | 299.9 | 19,192 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 300.82 per share. | 10 Feb 2023 | 11 | 65,765 (0%) | 0% | 300.8 | 3,309 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 296.00 per share. | 10 Feb 2023 | 2 | 66,038 (0%) | 0% | 296 | 592 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 10,262 | 62,546 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 7,866 | 70,412 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 6,194 | 52,284 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 298.77 per share. | 09 Aug 2022 | 679 | 46,519 (0%) | 0% | 298.8 | 202,865 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 297.54 per share. | 09 Aug 2022 | 292 | 47,198 (0%) | 0% | 297.5 | 86,882 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 299.79 per share. | 09 Aug 2022 | 283 | 46,236 (0%) | 0% | 299.8 | 84,841 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 301.68 per share. | 09 Aug 2022 | 74 | 46,090 (0%) | 0% | 301.7 | 22,324 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 300.64 per share. | 09 Aug 2022 | 72 | 46,164 (0%) | 0% | 300.6 | 21,646 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 250.10 per share. | 17 Mar 2022 | 2,799 | 47,390 (0%) | 0% | 250.1 | 700,030 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 251.24 per share. | 17 Mar 2022 | 34 | 47,356 (0%) | 0% | 251.2 | 8,542 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.86 per share. | 24 Feb 2022 | 2,590 | 50,514 (0%) | 0% | 227.9 | 590,157 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 230.97 per share. | 24 Feb 2022 | 115 | 50,294 (0%) | 0% | 231.0 | 26,562 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 231.80 per share. | 24 Feb 2022 | 87 | 50,207 (0%) | 0% | 231.8 | 20,167 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 230.26 per share. | 24 Feb 2022 | 77 | 50,409 (0%) | 0% | 230.3 | 17,730 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 228.89 per share. | 24 Feb 2022 | 28 | 50,486 (0%) | 0% | 228.9 | 6,409 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 232.78 per share. | 24 Feb 2022 | 18 | 50,189 (0%) | 0% | 232.8 | 4,190 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.51 per share. | 17 Feb 2022 | 4,114 | 53,623 (0%) | 0% | 232.5 | 956,546 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 229.52 per share. | 17 Feb 2022 | 218 | 53,405 (0%) | 0% | 229.5 | 50,035 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 233.48 per share. | 17 Feb 2022 | 120 | 53,104 (0%) | 0% | 233.5 | 28,018 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 230.42 per share. | 17 Feb 2022 | 101 | 53,304 (0%) | 0% | 230.4 | 23,272 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 232.04 per share. | 17 Feb 2022 | 80 | 53,224 (0%) | 0% | 232.0 | 18,563 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 237.74 per share. | 10 Feb 2022 | 1,230 | 58,027 (0%) | 0% | 237.7 | 292,420 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 233.92 per share. | 10 Feb 2022 | 100 | 57,927 (0%) | 0% | 233.9 | 23,392 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 234.94 per share. | 10 Feb 2022 | 78 | 57,849 (0%) | 0% | 234.9 | 18,325 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 235.87 per share. | 10 Feb 2022 | 70 | 57,779 (0%) | 0% | 235.9 | 16,511 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Sale of securities on an exchange or to another person at price $ 236.86 per share. | 10 Feb 2022 | 42 | 57,737 (0%) | 0% | 236.9 | 9,948 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 13,952 | 48,995 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 10,262 | 59,257 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 3,500 | 35,043 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.57 per share. | 24 Feb 2021 | 1,036 | 31,432 (0%) | 0% | 217.6 | 225,403 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 211.75 per share. | 17 Feb 2021 | 2,000 | 32,468 (0%) | 0% | 211.8 | 423,500 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.16 per share. | 10 Feb 2021 | 1,230 | 34,468 (0%) | 0% | 214.2 | 263,417 | Common Stock |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 13,952 | 35,698 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 6,194 | 21,746 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 2,814 | 15,552 (0%) | 0% | 0 | Common Stock |